Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (OTCBB - OTCQB:SNGX)

0.829
Delayed Data
As of Sep 23
 +0.029 / +3.62%
Today’s Change
0.44
Today|||52-Week Range
1.44
-26.64%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close0.80
Today’s open0.85
Day’s range0.78 - 0.85
Volume95,291
Average volume (3 months)87,530
Market cap$27.8M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+30.23%
Earnings growth (this year)+50.00%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+24.50%
P/E ratioNM
Price/Sales3.36
Price/Book--

Competitors

 Today’s
change
Today’s
% change
APTOAptose Biosciences I...-0.00-0.00%
KDUSCadus Corp0.000.00%
ORPNBio Blast Pharma Ltd-0.01-0.30%
PZRXPhaseRx Inc+0.04+1.57%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$8.8M
Annual profit (last year)-$7.8M
Net profit margin-89.31%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer &
Senior Vice President
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts

Search for Jobs